DE69233652D1 - Nukleotidsequenzen, die für die veränderlichen bereiche der alpha-ketten menschlicher t-zell-rezeptoren kodieren sowie ihre verwendungen - Google Patents

Nukleotidsequenzen, die für die veränderlichen bereiche der alpha-ketten menschlicher t-zell-rezeptoren kodieren sowie ihre verwendungen

Info

Publication number
DE69233652D1
DE69233652D1 DE69233652T DE69233652T DE69233652D1 DE 69233652 D1 DE69233652 D1 DE 69233652D1 DE 69233652 T DE69233652 T DE 69233652T DE 69233652 T DE69233652 T DE 69233652T DE 69233652 D1 DE69233652 D1 DE 69233652D1
Authority
DE
Germany
Prior art keywords
sequences
human
nucleotide sequences
cell receptors
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69233652T
Other languages
English (en)
Other versions
DE69233652T2 (de
Inventor
Thierry Hercend
Frederic Triebel
Sergio Roman-Roman
Laurent Ferradini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9101487A external-priority patent/FR2672616B1/fr
Priority claimed from FR9104527A external-priority patent/FR2675156B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69233652D1 publication Critical patent/DE69233652D1/de
Application granted granted Critical
Publication of DE69233652T2 publication Critical patent/DE69233652T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69233652T 1991-02-08 1992-02-07 Nukleotidsequenzen, die für die veränderlichen bereiche der alpha-ketten menschlicher t-zell-rezeptoren kodieren sowie ihre verwendungen Expired - Lifetime DE69233652T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9101487A FR2672616B1 (fr) 1991-02-08 1991-02-08 Sequences nucleotidiques codant pour des regions variables de chaines alpha des recepteurs de lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques.
FR9101487 1991-02-08
FR9104527 1991-04-12
FR9104527A FR2675156B1 (fr) 1991-04-12 1991-04-12 Sequences nucleotidiques codant pour des regions variables de chaines alpha des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques.
PCT/FR1992/000111 WO1992013949A1 (fr) 1991-02-08 1992-02-07 Sequences nucleotidiques codant pour des regions variables de chaines alpha des recepteurs des lymphocytes humains ainsi que leurs applications

Publications (2)

Publication Number Publication Date
DE69233652D1 true DE69233652D1 (de) 2006-10-12
DE69233652T2 DE69233652T2 (de) 2007-09-27

Family

ID=26228502

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69233804T Expired - Lifetime DE69233804D1 (de) 1991-02-08 1992-02-07 Nukleotidsequenzen, die für die veränderlichen Bereiche der Alpha-Ketten menschlicher T-Zell-Rezeptoren kodieren sowie ihre Verwendungen
DE69233652T Expired - Lifetime DE69233652T2 (de) 1991-02-08 1992-02-07 Nukleotidsequenzen, die für die veränderlichen bereiche der alpha-ketten menschlicher t-zell-rezeptoren kodieren sowie ihre verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69233804T Expired - Lifetime DE69233804D1 (de) 1991-02-08 1992-02-07 Nukleotidsequenzen, die für die veränderlichen Bereiche der Alpha-Ketten menschlicher T-Zell-Rezeptoren kodieren sowie ihre Verwendungen

Country Status (12)

Country Link
US (3) US5817511A (de)
EP (2) EP1721978B1 (de)
JP (1) JPH05509234A (de)
KR (1) KR100242278B1 (de)
AT (2) ATE504650T1 (de)
AU (1) AU660660B2 (de)
CA (1) CA2079879C (de)
DE (2) DE69233804D1 (de)
DK (1) DK0529033T3 (de)
ES (1) ES2271940T3 (de)
IE (1) IE920413A1 (de)
WO (1) WO1992013949A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
US7294712B2 (en) * 1990-06-04 2007-11-13 Aventis Pharma S.A. Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
JPH05509234A (ja) * 1991-02-08 1993-12-22 ルセル　ユクラフ ヒトＴリンパ球レセプターのα鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用
IE920447A1 (en) * 1991-02-12 1992-08-12 Roussel Uclaf NUCLEOTIDE SEQUENCES CODING FOR ß-CHAIN VARIABLE REGIONS OF¹HUMAN T-LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDE SEGMENTS¹AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
DE4225569C2 (de) * 1992-08-03 1996-04-25 Max Planck Gesellschaft Verwendung einer Sonde zur Tumordiagnostik oder Tumortherapie
JP3875730B2 (ja) * 1993-02-22 2007-01-31 サノフィ・アベンティス株式会社 自己免疫疾患の予防治療剤
CA2188182A1 (en) * 1994-04-18 1995-10-26 Steven M. Friedman Conserved t-cell receptor sequences
EP1095948A1 (de) * 1999-10-28 2001-05-02 Universitätsklinikum Freiburg Idiotype Impstoffe
KR100363271B1 (ko) * 2000-06-12 2002-12-05 주식회사 동진쎄미켐 포토레지스트 리무버 조성물
US20060275747A1 (en) * 2001-12-07 2006-12-07 Hardy Stephen F Endogenous retrovirus up-regulated in prostate cancer
JP2005535308A (ja) 2002-06-13 2005-11-24 カイロン コーポレイション Ｈｍｌ−２ポリペプチド発現用ベクター
EP1517995A4 (de) * 2002-07-03 2007-07-11 Inst Scient Res Inc Zusammensetzungen und verfahren zum nachweis der expression von genen der variablen menschlichen t-zellrezeptor-familie
FR2863274B1 (fr) 2003-12-05 2012-11-16 Commissariat Energie Atomique Procede d'evaluation quantitative d'un rearrangement ou d'une recombinaison genetique ciblee d'un individu et ses applications.
EP2044949A1 (de) 2007-10-05 2009-04-08 Immutep Verwendung von rekombinantem LAG-3 oder Derivaten daraus zur Auslösung einer Monozyten-Immunreaktion
US8497071B2 (en) * 2009-06-29 2013-07-30 California Institute Of Technology Isolation of unknown rearranged T-cell receptors from single cells
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
CU24481B1 (es) 2014-03-14 2020-03-04 Immutep Sas Moléculas de anticuerpo que se unen a lag-3
US10202640B2 (en) * 2014-05-07 2019-02-12 The Board Of Trustees Of The Leland Stanford Junior University Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874845A (en) * 1984-06-13 1989-10-17 Massachusetts Institute Of Technology T lymphocyte receptor subunit
EP0200350A3 (de) * 1985-04-15 1987-05-13 The Ontario Cancer Institute Nukleinsäure mit Code für ein T-Zellen-Antigenrezeptor-Polypeptid
EP0616811A1 (de) * 1985-12-03 1994-09-28 T Cell Sciences, Inc. Zellfreier T-Zell-Antigenrezeptor und dessen klinische Verwendungen
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
US5216132A (en) * 1990-01-12 1993-06-01 Protein Design Labs, Inc. Soluble t-cell antigen receptor chimeric antigens
JPH05509234A (ja) * 1991-02-08 1993-12-22 ルセル　ユクラフ ヒトＴリンパ球レセプターのα鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用

Also Published As

Publication number Publication date
AU660660B2 (en) 1995-07-06
DK0529033T3 (da) 2007-01-08
US6114516A (en) 2000-09-05
AU1360392A (en) 1992-09-07
DE69233652T2 (de) 2007-09-27
ATE504650T1 (de) 2011-04-15
WO1992013949A1 (fr) 1992-08-20
IE920413A1 (en) 1992-08-12
US5817511A (en) 1998-10-06
EP0529033B1 (de) 2006-08-30
US5798231A (en) 1998-08-25
CA2079879A1 (fr) 1992-08-09
EP0529033A1 (de) 1993-03-03
ES2271940T3 (es) 2007-04-16
ATE338134T1 (de) 2006-09-15
DE69233804D1 (de) 2011-05-19
KR100242278B1 (ko) 2000-02-01
CA2079879C (fr) 2007-11-06
EP1721978B1 (de) 2011-04-06
JPH05509234A (ja) 1993-12-22
EP1721978A1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
DE69233652D1 (de) Nukleotidsequenzen, die für die veränderlichen bereiche der alpha-ketten menschlicher t-zell-rezeptoren kodieren sowie ihre verwendungen
BR9007197A (pt) Cadeia pesada,cadeia leve e molecula de anticorpo,sequencia de dna,vetor de clonagem,celula hospedeira,processos para produzir uma sequencia de anticorpo e um produto de anticorpo,composicao terapeutica e processo de terapia ou diagnose
DE69428214T2 (de) Transformierender wachstumsfaktor alpha h1
DE69024291D1 (de) Rezeptoren für Tumornekrosisfaktor-alpha und -beta
DE69617440D1 (de) Isolierte nukleinsäuremoleküle, peptide die mit hla-a2 moleküle (mhc) komplexe bilden, sowie deren verwendungen
CY1105687T1 (el) Οικογενεια ανοσορυθμιστων που οριζονται ως υποδοχεις λευκοκυτταρων παρομοιοι με ανοσοσφαιρινες (lir)
ATE355074T1 (de) Hybrid aus interferon-alpha und immunglobulin fc- fragment verbunden durch ein nicht immunogenes peptid
KR970705405A (ko) 사람 케모킨 폴리펩타이드(Human Chemokine Polypeptides)
DK0669979T3 (da) C-C CKR-1, kemokinreceptor
HUT63652A (en) Process for producing cd44 surface protein variants, dna sequences encoding them and antibodies against them, as well as their application in diagnosis and therapy
ATE173023T1 (de) Dna-sequenzen kodierend für das polypeptid gelonin
Suran et al. N-terminal sequences of heavy and light chains of leopard shark immunoglobulins: evolutionary implications.
ATE252638T1 (de) Das humane jtvi-gen überlappt mit dem pms2-gen
KR970070198A (ko) 항-파스 재조합 항체 및 이에 대한 디엔아이
AR010337A1 (es) Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacuna
JPWO2021202678A5 (de)
Fellah et al. Structure and diversity of the T-cell receptor α chain in the Mexican axolotl
KR860006484A (ko) 단백질 또는 당단백질의 제조방법
DE69332583T2 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
IT8821701A0 (it) Dna plasmidico ricombinante ppr il2 19 codificante la sintesi dell'interleuchina 2 umana, metodo per la sua ingenierizzazione e ceppo del batterio escherichia coli vniigenetika vl 903 (ppr il2 19) producente interleuchina 2 umana che lo contiene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition